India and the Coronary Stent Market-Reference-Cited by-同舟云学术

India and the Coronary Stent Market

Published:2017-05-16 Issue:20 Volume:135 Page:1879-1881
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Wadhera Priya¹,Alexander Thomas¹,Nallamothu Brahmajee K.¹

Affiliation:

1. From Michigan Integrated Center for Health Analytics and Medical Prediction, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor (P.W., B.K.N.); and Kovai Medical Center and Hospital, Coimbatore Tamil Nadu, India (T.A.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.117.028191

Reference5 articles.

1. Government of India, New Delhi: February 13, 2017.;National Pharmaceuticals Pricing Authority Order;Gazette of India Extraordinary

2. Memorandum: Display of Price Calculation Sheets for Notified Ceiling Price of Coronary Stents on NPPA’s website. Government of India New Delhi. February 28 2017. http://www.nppaindia.nic.in/order/Displayofpriecalculation28022017.pdf Accessed March 1 2017.

3. National Pharmaceutical Pricing Authority slashes stent prices by up to 85%.;Nagarajani R;The Times of India,2017

4. Building the Case for Clopidogrel as a World Health Organization Essential Medicine

5. Cardiovascular Diseases in India

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular Diseases Among Indian Older Adults: A Comprehensive Review;Cardiovascular Therapeutics;2024-01

2. Financial burden of coronary artery bypass grafting in India: implications for catastrophic health expenditure and healthcare access;Indian Journal of Thoracic and Cardiovascular Surgery;2023-10-26

3. Usefulness of Off-Label Use of Coronary Drug-Eluting Stents as Bailout for Patients with Critical Limb Ischemia and Infrapopliteal Arterial Occlusive Disease;Indian Journal of Vascular and Endovascular Surgery;2023

4. Does India need a new pharmaceutical policy? Examining the implications of the drug price control order;The International Journal of Health Planning and Management;2022-08-18

5. Real-World Clinical Outcomes of Indigenous Biodegradable Polymer Drug-Eluting Stents;Cureus;2021-09-11